Professor Nada Hamad

“My Fulbright project at Fred Hutch Cancer Center aims to enhance access to cellular therapies by leveraging big data and scalable laboratory innovations. By addressing social determinants of health and advancing cost-effective solutions, I aspire to expand equitable access to life-saving treatments for vulnerable populations in Australia and globally.”

Professor Nada Hamad, 2023 Fulbright Future Scholar, Funded by The Kinghorn Foundation
St Vincent’s Hospital Sydney to The Fred Hutchinson Cancer Centre| Cellular Therapy

Professor Nada Hamad is a Senior Staff Specialist in Transplant and Cellular Therapies and a Clinical and Laboratory Haematologist at St Vincent’s Hospital Sydney. As the President of the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT), she is a leader in hematopoietic stem cell transplantation and cellular therapies.

Nada’s Fulbright project at the Fred Hutch Cancer Center focuses on enhancing accessibility to cellular therapies in Australia by leveraging big data and laboratory innovations. The project aims to mitigate the impact of social determinants of health and develop cost-effective, scalable solutions to expand access to life-saving treatments globally.

Find out more about the current cohort of Fulbright Scholars HERE.